A case of Guillain-Barre syndrome after the second dose of AstraZeneca COVID-19 vaccination

被引:6
|
作者
Bazrafshan, Hanieh [1 ]
Jahromi, Leila Sadat Mohamadi [2 ]
Parvin, Reyhaneh [3 ]
Ashraf, Alireza [4 ]
机构
[1] Shiraz Univ Med Sci, Dept Neurol, Clin Neurol Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Shiraz Med Sch, Faghihi Hosp, Dept Phys Med & Rehabil, Shiraz, Iran
[3] Shiraz Univ Med Sci, Faghihi Hosp, Dept Phys Med & Rehabil, Shiraz, Iran
[4] Shiraz Univ Med Sci, Shiraz Med Sch, Dept Phys Med & Rehabil, Shiraz, Iran
关键词
AstraZeneca vaccine; COVID-19; Guillain-Barre syndrome;
D O I
10.5606/tftrd.2022.9984
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Coronavirus disease 2019 (COVID-19) is a novel virus that primarily involves the respiratory system. Due to the COVID-19 pandemic, an extensive vaccination program is underway worldwide. Herein, we present a 68-year-old woman with paresthesia of both hands associated with gait instability, which started three to four days after receiving the second dose of Oxford/AstraZeneca vaccine against the COVID-19 infection. The acute inflammatory demyelinating polyradiculoneuropathy subtype of the Guillain-Barre syndrome, which is the most common subtype, was diagnosed. Regardless of the beneficial effects of the vaccines, this case report aimed to evaluate their severe complications, such as Guillain-Barre syndrome, to reduce their occurrence in the future.
引用
收藏
页码:295 / 299
页数:5
相关论文
共 50 条
  • [31] A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine
    Rao, Shiavax J.
    Khurana, Sahiba
    Murthy, Gayathri
    Dawson, Elliot T.
    Jazebi, Noushin
    Haas, Christopher J.
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2021, 11 (05): : 597 - 600
  • [32] Post COVID-19 vaccination Guillain-Barre syndrome: three cases
    Tabatabaee, Seyedehnarges
    Rezania, Fatemeh
    Alwedaie, Sayed Mohammed Jawad
    Malekdar, Ensieh
    Badi, Zahra
    Tabatabaei, Seyed Mohammad
    Mirzaasgari, Zahra
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [33] Neurolymphomatosis mimicking a Guillain-Barre syndrome triggered by COVID-19 vaccination
    Colombo, Daniele
    Falasca, Laura
    Monardo, Francesca
    D'Ambrosio, Mario
    Di Napoli, Arianna
    Salerno, Antonio
    Del Nonno, Franca
    Comanducci, Giovanna
    NEUROPATHOLOGY, 2025, 45 (01) : 76 - 82
  • [34] COVID-19 and Guillain-Barre Syndrome: A fortuitous relationship?
    Pinera-Castro, Hector J.
    REVISTA MEXICANA DE NEUROCIENCIA, 2020, 21 (05): : 205 - 214
  • [35] Guillain-Barre syndrome following COVID-19 vaccine: A case report
    Fakhari, Mohammad Sadegh
    Poorsaadat, Leila
    Mahmoodiyeh, Behnam
    CLINICAL CASE REPORTS, 2022, 10 (10):
  • [36] Guillain-Barre syndrome in 220 patients with COVID-19
    Finsterer, Josef
    Scorza, Fulvio A.
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01)
  • [37] Guillain-Barre Syndrome and COVID-19 Vaccines: A Comment
    Beuy, Joob
    Wiwanitkit, Viroj
    TURKISH JOURNAL OF NEUROLOGY, 2021, 27 : 61 - 61
  • [38] Guillain-Barre syndrome in 220 patients with COVID-19
    Josef Finsterer
    Fulvio A. Scorza
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [39] Guillain-Barre Syndrome in a Child Infected with COVID-19
    Tabatabaei, Sedigheh Rafiei
    Shariatpanahi, Ghazal
    Azadkiya, Romina
    Karimzadeh, Parvaneh
    Karimi, Abdollah
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2022, 10
  • [40] Guillain-Barre syndrome secondary to COVID-19 infection: A case report
    Tran, Dena. H. H.
    Basra, Dalwinder
    Bilgrami, Zaid
    Challa, Suryanarayana. R. R.
    Kwon, Christina
    Marciniak, Ellen
    Verceles, Avelino. C. C.
    CLINICAL CASE REPORTS, 2023, 11 (04):